Medical device company Medtronic and the ASGE have collaborated to create the Medtronic Health Equity Assistance Program, which aims to improve access to colorectal cancer screening technologies in underserved U.S. communities. According to a Medtronic press release, the initiative will include the donation of 50 Medtronic GI Genius intelligent endoscopy modules, which have the potential to improve detection of polyps that can lead to CRC, to endoscopy centers throughout the U.S. In addition, Amazon Web Services (AWS) is donating AWS computing credits that support the initiative, as well as the development of future Medtronic health screening technologies.
Author: Praveen Suthrum
Paul Feuerstadt, MD, and Louis Korman, MD, spoke with Becker’s about how a study published in The New England Journal of Medicine could change how the gastroenterology industry treats Clostridioides difficile. The two physicians participated in the study, which showed that oral microbiome therapy SER-109 could be helpful in fighting recurrent C. diff. Question: How do you think the findings from this study will affect the way the industry treats Clostridioides difficile? Dr. Paul Feuerstadt: The SER-109 study was the first phase 3 clinical trial to publish their results in manuscript form considering a microbiota-based live biotherapeutic treatment. This is exciting because we believe the future…
Pancreatic cancer is not one of the most frequently diagnosed cancers, but it is one of the most lethal due to its early local extension and metastatic behaviour. Some of the reasons for this high fatality rate are late diagnosis of the disease, especially since symptoms are unspecific and appear rather late, and limited therapeutic options. Using patient samples provided by a number of clinical collaborators, researchers from the Spanish National Cancer Research Centre (CNIO), led by Núria Malats, and the European Molecular Biology Laboratory (EMBL) in Heidelberg, led by Peer Bork, have found a molecular signature of 27 microorganisms in stool…
Nine percent of gastroenterologists reported having suicidal thoughts, according to Medscape’s “Physician Suicide Report 2022.” Published March 4, Medscape based its report on a survey of 13,069 physicians in 29 specialties conducted from June 29 to Sept. 26, 2021. Four notes: 1. Pathologists (13 percent), general surgeons (12 percent) and oncologists (12 percent) were the specialist groups with the highest rates of suicidal thoughts. 2. Specialities with the lowest suicidal ideation were nephrology (2 percent), rheumatology (5 percent) and ophthalmology (6 percent).
Since its introduction into clinical use in 2001, capsule endoscopy has been a game changer, enabling gastroenterologists to noninvasively image the entire small bowel.1 On the 20th anniversary of capsule endoscopy in clinical practice, it is important to look back at its beginnings, clinical success, and extension into the upper gastrointestinal tract and colon, as well as peer into the future, with the release of new types of capsules and the integration of artificial intelligence into this revolutionary technology.
From new guideline recommendations to a concert featuring the American College of Gastroenterology’s official band, a lot is being done to help raise awareness of the importance of screening for colorectal cancer. So how can you help increase screening rates in your own community? Get inspired with these creative initiatives shared by Dr. Neil Nandi and Dr. Samir Shah, President of the American College of Gastroenterology.
We are proud to announce the 2022 recipients of our annual recognition prizes, given in honor of outstanding contributions and achievements in gastroenterology and hepatology. We look forward to celebrating the recipients at Digestive Disease Week® in May 2022. Learn more about our 2022 AGA recognition prize recipients below.
1. Zymergen engineers better microbes that make useful molecules, which are part of all the materials in our daily lives. We are engineering biology predictably, reliably and to levels of performance unattainable through traditional R&D methods. Our comprehensive approach brings together technology, automation, and biology with the most sophisticated capabilities in each.
Vivante Health, a digital health company that wants to bring virtual tools to digestive care raised $16 million in Series A funding led by 7wireVentures, Robert Garber, partner at 7wireVentures, tells Axios exclusively. Why it matters: Digital health companies focused on heart and metabolic issues have seen sky-high fundraises and valuations in recent years, but far less attention has gone towards digitizing support for gastrointestinal (GI) conditions. “These conditions have been unfairly stigmatized,” says William Snyder, Vivante’s CEO. “And I think people are getting more secure in discussing different aspects of their health, such as behavioral health.””Finally, someone’s paying attention to…
Celestine Tention’s grandmother used to chase antacid tablets with ginger ale, one after another, day after day. Years passed before the pain was so bad that she had to get help, but by then there wasn’t much doctors could do. Tention’s grandmother moved from her home in Harlem to live with Tention’s family, and they did their best to care for her.